Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
BEAM
$24.40
+0.04%
BEAM
· Beam Therapeutics Inc.
$24.40
+0.01 (+0.04%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.53B
Shares
103.29M
Volume · Oct 1
1.7M
Avg daily vol (3M)
1.98M
All webcasts
Earnings call · FY2021 Q4
Beam Therapeutics Inc. (BEAM) Q4 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$51.07M
+851050% YoY
Net income · derived Q4
-$64.71M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 10, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 28, 2022 · complete as-filed document